Medrol Dosepak and Mifepristone Tablets (For Ending Early Pregnancy)
Determining the interaction of Medrol Dosepak and Mifepristone Tablets (For Ending Early Pregnancy) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using miFEPRIStone together with methylPREDNISolone is generally not recommended. Combining these medications may significantly reduce the effects of methylPREDNISolone. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:CONTRAINDICATED: Mifepristone is a potent antiglucocorticoid and may antagonize the effects of corticosteroids. In animals, mifepristone at dosages of 10 to 25 mg/kg inhibited the action of dexamethasone. In human, the antiglucocorticoid action occurred at dosages of 4.5 mg/kg or greater, as indicated by a compensatory elevation of adrenocorticotropic hormone (ACTH) and cortisol. The efficacy of chronic corticosteroid therapy, including inhaled corticosteroids, may be reduced for 3 to 4 days after a single dose of mifepristone. Pharmacokinetically, mifepristone may increase the plasma concentrations of corticosteroids by inhibiting their metabolism via CYP450 3A4. However, the clinical impact has not been studied. Dexamethasone, specifically, may also decrease the blood levels of mifepristone by inducing its metabolism via CYP450 3A4.
MANAGEMENT: The use of mifepristone is considered contraindicated in patients on long-term corticosteroid therapy. When intended for daily use to control hyperglycemia secondary to hypercortisolism in patients with endogenous Cushing's syndrome, mifepristone is also contraindicated in those patients who require systemic corticosteroids for serious medical conditions or illnesses, such as immunosuppression after organ transplantation. Because mifepristone is eliminated slowly from the body, drug interactions may be observed for a prolonged period following discontinuation (approximately 2 to 3 weeks if mifepristone had been administered chronically to steady state).
- "Product Information. Korlym (mifepristone)." Corcept Therapeutics Incorporated, Menlo Park, CA.
- "Product Information. Mifeprex (mifepristone)" Danco Laboratories, New York, NY.
Generic Name: methylprednisolone
Brand name: Medrol, Medrol Dosepak, MethylPREDNISolone Dose Pack, A-methapred, Depo-Medrol, Solu-Medrol
Synonyms: n.a.
Generic Name: mifepristone
Brand name: Korlym, Mifeprex
Synonyms: Mifepristone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Medrol Dosepak-Mifepristone Tablets (For High Blood Sugar)
- Medrol Dosepak-Migalastat
- Medrol Dosepak-Migalastat Hydrochloride
- Medrol Dosepak-Migergot
- Medrol Dosepak-Migergot Suppository
- Medrol Dosepak-Miglitol
- Mifepristone Tablets (For Ending Early Pregnancy)-Medroloan II SUIK
- Mifepristone Tablets (For Ending Early Pregnancy)-Medroloan SUIK
- Mifepristone Tablets (For Ending Early Pregnancy)-Medrox (Capsaicin and Menthol Patch)
- Mifepristone Tablets (For Ending Early Pregnancy)-Medrox (Methyl Salicylate, Menthol, and Capsaicin Cream and Ointment)
- Mifepristone Tablets (For Ending Early Pregnancy)-Medrox (Methyl Salicylate, Menthol, and Capsaicin Patch)
- Mifepristone Tablets (For Ending Early Pregnancy)-Medrox-Rx